Authors:
VANDERMEER M
DEBOER JAM
HOMPES PGA
SCHOEMAKER J
Citation: M. Vandermeer et al., OCTREOTIDE, A SOMATOSTATIN ANALOG, ALTERS OVARIAN SENSITIVITY TO GONADOTROPIN STIMULATION AS MEASURED BY THE FOLLICLE-STIMULATING-HORMONE THRESHOLD IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction (Oxford. Print), 13(6), 1998, pp. 1465-1469
Authors:
VANDERMEER M
HOMPES PGA
DEBOER JAM
SCHATS R
SCHOEMAKER J
Citation: M. Vandermeer et al., COHORT SIZE RATHER THAN FOLLICLE-STIMULATING-HORMONE THRESHOLD LEVEL DETERMINES OVARIAN SENSITIVITY IN POLYCYSTIC-OVARY-SYNDROME, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 423-426
Authors:
BROEKMANS FJ
HEITBRINK MA
HOMPES PGA
SCHOUTE E
FALKE T
SCHOEMAKER J
Citation: Fj. Broekmans et al., QUANTITATIVE MRI OF UTERINE LEIOMYOMAS DURING TRIPTORELIN TREATMENT -REPRODUCIBILITY OF VOLUME ASSESSMENT AND PREDICTABILITY OF TREATMENT RESPONSE, Magnetic resonance imaging, 14(10), 1996, pp. 1127-1135
Authors:
SCHEELE F
HOMPES PGA
LAMBALK CB
SCHOUTE E
BROEKMANS FJ
SCHOEMAKER J
Citation: F. Scheele et al., THE GNRH CHALLENGE TEST - A QUANTITATIVE MEASURE OF PITUITARY DESENSITIZATION DURING GNRH AGONIST ADMINISTRATION, Clinical endocrinology, 44(5), 1996, pp. 581-586
Authors:
BROEKMANS FJ
HOMPES PGA
LAMBALK CB
SCHOUTE E
BROEDERS A
SCHOEMAKER J
Citation: Fj. Broekmans et al., SHORT-TERM PITUITARY DESENSITIZATION - EFFECTS OF DIFFERENT DOSES OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST TRIPTORELIN, Human reproduction, 11(1), 1996, pp. 55-60
Authors:
VANDERMEER M
HOMPES PGA
SCHEELE F
SCHOUTE E
POPPSNIJDERS C
SCHOEMAKER J
Citation: M. Vandermeer et al., THE IMPORTANCE OF ENDOGENOUS FEEDBACK FOR MONOFOLLICULAR GROWTH IN LOW-DOSE STEP-UP OVULATION INDUCTION WITH FOLLICLE-STIMULATING-HORMONE IN POLYCYSTIC-OVARY-SYNDROME - A RANDOMIZED STUDY, Fertility and sterility, 66(4), 1996, pp. 571-576
Authors:
HOMPES PGA
KONINCKX PR
KENNEDY S
VANKAMP GF
VERSTRAETEN RA
CORNILLIE F
Citation: Pga. Hompes et al., SERUM CA-125 CONCENTRATIONS DURING MIDFOLLICULAR PHASE, A CLINICALLY USEFUL AND REPRODUCIBLE MARKER IN DIAGNOSIS OF ADVANCED ENDOMETRIOSIS, Clinical chemistry, 42(11), 1996, pp. 1871-1874
Authors:
BROEKMANS FJ
HOMPES PGA
HEITBRINK MA
NETELENBOS CC
ROOS JC
FALKE TM
SCHOEMAKER J
Citation: Fj. Broekmans et al., 2-STEP GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT OF UTERINE LEIOMYOMAS - STANDARD-DOSE THERAPY FOLLOWED BY REDUCED-DOSE THERAPY, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1208-1216
Authors:
SCHEELE F
VANDERMEER M
LAMBALK CB
SCHOUTE E
SCHOEMAKER J
HOMPES PGA
Citation: F. Scheele et al., EXPLORING THE RECOVERY PHASE AFTER TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE-AGONIST FOR OVULATION INDUCTION IN POLYCYSTIC-OVARY-SYNDROME - 3 PILOT TRIALS, European journal of obstetrics, gynecology, and reproductive biology, 62(2), 1995, pp. 221-224
Authors:
VANDERMEER M
HOMPES PGA
SCHEELE F
SCHOUTE E
VEERSEMA S
SCHOEMAKER J
Citation: M. Vandermeer et al., FOLLICLE-STIMULATING-HORMONE (FSH) DYNAMICS OF LOW-DOSE STEP-UP OVULATION INDUCTION WITH FSH IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 9(9), 1994, pp. 1612-1617
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., THE EFFECTS OF A GONADOTROPIN-RELEASING-HORMONE AGONIST ON TREATMENT WITH LOW-DOSE FOLLICLE-STIMULATING-HORMONE IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8(5), 1993, pp. 699-704
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., PULSATILE GONADOTROPIN-RELEASING-HORMONE STIMULATION AFTER MEDIUM-TERM PITUITARY SUPPRESSION IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8, 1993, pp. 197-199
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., THE RELATIONSHIP BETWEEN FOLLICLE-STIMULATING-HORMONE DOSE AND LEVEL AND ITS RELEVANCE FOR OVULATION INDUCTION WITH ADJUVANT GONADOTROPIN-RELEASING HORMONE-AGONIST TREATMENT, Fertility and sterility, 60(4), 1993, pp. 620-625